Abstract:Summary objective: To assess the clinical features and outcomes of hematological disease patients with Candida tropicalis bloodstream infections and determine the antifungal susceptibility of C. tropicalis . Methods: This is a retrospective, single-center, observational study conducted in the Department of Hematology at The First Affiliated Hospital of Guangxi Medical University from January 2013 to December 2021. A total of 26 hematological disease patients with C. tropicalis bloodstream infections were enrolled, and their clinical features, treatment plans, and prognoses were assessed. Univariate analysis was performed by Kaplan–Meier analysis and multivariate analysis was conducted using a Cox regression model. The antifungal susceptibility of C. tropicalis was determined from patient blood cultures. Results: The patients had a mean age of 35 years (range: 10–65 years), 50% were male (13/26) and 88.5% had hematologic malignancies (23/26) while the remaining three patients included two cases of severe aplastic anemia and one case of β-thalassemia. All patients had neutropenia. Seven patients were initially given azole alone (26.9%), five of whom failed treatment and died (71.4%). Fifteen patients were treated with echinocandin (57.7%), three of whom failed treatment and died (20.0%), and eight patients were treated with amphotericin B (30.8%), two of whom failed treatment and died (25.0%). The total and attributable mortality rates were 42.3 and 34.6%, respectively. Univariate analysis showed that there are six risk factors for attributable deaths among hematological disease patients with C. tropicalis blood infections. These risk factors included septic shock, Pitt bacteremia scores ≥4, procalcitonin levels ≥10 ng/mL, positive plasma (1,3)- β-D glucan assay, serum albumin levels <30.0 g/L, time from fever to antifungal treatment initiation ≥5 days and time between neutropenia and antifungal treatment ≥10 days. Moreover, skin and mucosal infections and a treatment schedule that included amphotericin B and drug combinations are protective factors for attributable deaths. Multivariate analysis showed that septic shock ( p = 0.006) was an independent risk factor for attributable death. All isolates were sensitive to flucytosine and amphotericin B. The intermediate or resistance of C. tropicalis to fluconazole, itraconazole and voriconazole were 41.7, 50, and 41.7%, respectively. Conclusion: Hematological disease patients with C. tropicalis bloodstream infections had a high mortality rate, and early antifungal therapy significantly reduced mortality. Candida tropicalis was highly resistant to azole drugs and sensitive to flucytosine and amphotericin B. According to our study, the preferred agent is amphotericin B and drug combinations should be considered for severe infections.

Risk Factors and Prognostic Analysis of Candida Tropicalis Fungemia in Patients with Different Immune Function

Clinical analysis of 14 cases of candidemia

Clinical Features, Strain Distribution, Antifungal Resistance and Prognosis of Patients with Non-albicans Candidemia: A Retrospective Observational Study.

Risk Factors for Candida tropicalis Fungemia in Patients with Cancer

A clinical analysis of Candida tropicalis bloodstream infections associated with hematological diseases, and antifungal susceptibility: a retrospective survey

[Analysis of Clinical Characteristics and Risk Factors Associated with Prognosis of Patients with Candidemia].

The clinical and prognostic analysis of 50 patients with cryptococcemia

Analysis of risk factors and prognosis of patients with candidemia

Fungemia: A Retrospective Clinical Analysis of 17 Patients

Clinical Features and Prognostic Risk Factors of Candidemia in Non-Intensive Care Unit Wards

[Clinical High Risk Factors and Prognosis of 25 Pulmonary Mucormycosis Cases].

Candidemia Tropicalis in Acute Leukemia Patients:Clinical Characteristics and Risks Factors

Etiology and risk factors analysis of oral candidiasis in patients with chronic obstructive pulmonary disease

Clinical Retrospective Analysis of 69 Patients with Fungemia

Risk Factors of Nosocomial Invasive Candidemia:Analysis and Prognosis of 59 Cases of Candidemia

Epidemiology, Species Distribution, Antifungal Susceptibility and Mortality Risk Factors of Candidemia among Critically Ill Patients: a Retrospective Study from 2011 to 2017 in a Teaching Hospital in China

[Candida Species Distribution in the Patients with High Risk of Deep Fungal Infections and Relevant Risk Factors: a Prospective Cohort Study].

Poor prognosis of Candida tropicalis among non-albicans candidemia: A retrospective multi-center cohort study, Korea

Clinical Analysis of 18 Malignant Hematological Patients with Fungemia

Comparative Analysis of Epidemiological and Clinical Characteristics Between Invasive Candida Infection Versus Colonization in Critically Ill Patients in a Tertiary Hospital in Anhui, China

Candidaemia: A 9-Year Retrospective Analysis of Epidemiology and Antimicrobial Susceptibility in Tertiary Care Hospitals in Western China